JOHNSON & JOHNSON (JNJ)
Clinical trial NCT06266663 updates: 1. completion date: 2026-06-30 → 2026-09-30 2. primary completion date: 2026-06-30 → 2026-09-30
Clinical trial NCT06266663 updates: 1. completion date: 2026-06-30 → 2026-09-30 2. primary completion date: 2026-06-30 → 2026-09-30
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical